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Nearly 100,000 people underwent total hip replacement (THR) in the United Kingdom in
2018, and most can expect it to last at least 25 years. However, some THRs fail and require
revision surgery, which results in worse outcomes for the patient and is costly to the health
service. Variation in the survival of THR implants has been observed between units and
reducing this unwarranted variation is one focus of the “Getting it Right First Time” (GIRFT)
program in the UK. We aimed to investigate whether the statistically improved implant sur-
vival of THRs in a high-performing unit is associated with the implants used or other factors
at that unit, such as surgical skill.
Methods and findings
We analyzed a national, mandatory, prospective, cohort study (National Joint Registry for
England, Wales, Northern Ireland and the Isle of Man [NJR]) of all THRs performed in
England and Wales. We included the 664,761 patients with records in the NJR who have
received a stemmed primary THR between 1 April 2003 and 31 December 2017 in one of
461 hospitals, with osteoarthritis as the only indication. The exposure was the unit (hospital)
in which the THR was implanted. We compared survival of THRs implanted in the “exem-
plar” unit with THRs implanted anywhere else in the registry. The outcome was revision sur-
gery of any part of the THR construct for any reason. Net failure was calculated using
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Kaplan–Meier estimates, and adjusted analyses employed flexible parametric survival
analysis.
The mean age of patients contributing to our analyses was 69.9 years (SD 10.1), and
61.1% were female. Crude analyses including all THRs demonstrated better implant sur-
vival at the exemplar unit with an all-cause construct failure of 1.7% (95% CI 1.3–2.3) com-
pared with 2.9% (95% CI 2.8–3.0) in the rest of the country after 13.9 years (log-rank test
P < 0.001). The same was seen in analyses adjusted for age, sex, and American Society of
Anesthesiology (ASA) score (difference in restricted mean survival time 0.12 years [95% CI
0.07–0.16; P < 0.001]). Adjusted analyses restricted to the same implants as the exemplar
unit show no demonstrable difference in restricted mean survival time between groups after
13.9 years (P = 0.34).
A limitation is that this study is observational and conclusions regarding causality cannot
be inferred. Our outcome is revision surgery, and although important, we recognize it is not
the only marker of success of a THR.
Conclusions
Our results suggest that the “better than expected” implant survival results of this exemplar
center are associated with implant choice. The survival results may be replicated by adopt-
ing key treatment decisions, such as implant selection. These decisions are easier to repli-
cate than technical skills or system factors.
Author summary
Why was this study done?
• In general, total hip replacement (THR) is safe and effective at reducing pain and restor-
ing mobility to people with end-stage arthritis of the hip.
• In England and Wales, in 2017, over 822 different types of hip replacement were used,
and different brands of hip replacement have been shown to have varying survival rates
at different follow-up timepoints. Reducing variation in outcomes following surgery is
an important aim of the National Health Service (NHS) in England and Wales.
• A national database of all hip replacements in England and Wales (the National Joint
Registry) has shown variation in survival rates between different hospitals, and a few
hospitals are highlighted by the database for having better survival rates than the others.
What did the researchers do and find?
• One of the hospitals with better survival rates for hip replacements than the others uses
only one type of hip replacement for all patients.
• We compared the survival of THRs implanted in this one hospital to THRs implanted
anywhere else in the country to look for factors that are associated with improved
survival.
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• When this hospital was compared with everyone else using the same hip replacement,
after taking the patients’ age, sex, and general health into account, they no longer had
better results than anyone else.
What do these findings mean?
• These findings suggest that the better results seen in this one hospital are not associated
with the skill of the surgeon or the setup of the hospital but are associated with the
choice of hip replacement.
• Future studies are needed to determine whether this is also the case across other brands
of hip replacement and to determine whether the choice of implant is similarly associ-
ated with implant survival across other specialties.
Introduction
Total hip replacement (THR) is one of the most successful operations of our time with nearly
100,000 performed in England, Wales, Northern Ireland, and the Isle of Man in 2017 [1, 2].
They have been shown in general to last about 25 years, but despite this, there is still variation
in the survival of implants across the UK [2, 3]. THR components may require changing (via
revision surgery) for one of several reasons including infection, wear, loosening, fracture, or
instability [2]. The need for future revision surgery can be influenced by preoperative patient
factors, implant factors, and surgical factors [4, 5]. It has previously been demonstrated that
THR revisions are not as effective in improving pain and function as the primary operation,
have a high chance of further revision, and are costly to the health service, as well as resulting
in exposure of patients to the additional pain and inconvenience of another operation [2, 6, 7].
Although implant survival is not the only marker of success [8], the cumulative probability of
revision of THRs is a readily available outcome measure because of the National Joint Registry
for England, Wales, Northern Ireland and the Isle of Man (NJR) a mandatory, national data-
base [9].
The NJR has collected data since 2003 and at the time of writing contains in excess of 1 mil-
lion records of primary THRs. In 2017, the NJR identified at least 415 different units (hospi-
tals) performing THRs using at least 822 different combinations of femoral stem and
acetabular socket [10, 11] and is thought to capture over 95% of primary hip and knee opera-
tions and 90% of revisions [2]. Every year, the NJR annual report lists units in which either a
higher or lower than expected rate of revision has been observed over the preceding years. The
units with a “better than expected” (above the 99.7% confidence limit) revision estimate may
offer an opportunity to learn from good practice and potentially reduce variation between
units.
The importance of reducing unwarranted variation across the whole National Health Ser-
vice (NHS) has been highlighted by the recent work of the “Getting it Right First Time”
(GIRFT) program [12]. This review has previously highlighted variation in adult elective
orthopedic services and makes clear the requirement to learn from good performance [13].
Investigating what may lead one unit to demonstrate better results than others is challeng-
ing because of the differing patient populations as well as issues with potential selection bias.
Patients may receive different types of implants based on factors such as age and sex, and as a
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result, outcomes are difficult to interpret. One unit in the NJR, the Royal Devon & Exeter NHS
Foundation Trust (RD&E), has been repeatedly identified as having “better than expected”
survival outcomes and is widely known for using only one femoral stem (the Exeter V40 femo-
ral stem) in all routine primary THRs regardless of patient factors, thus removing or reducing
selection bias [2]. This offers an opportunity to investigate whether “better than expected” sur-
vival results observed within this unit were due to a unit effect or because of the implants used.
Methods
We aimed to compare the cumulative revision estimates between the RD&E and the rest of the
country to investigate whether “better than expected” outcomes were due to the implants used
or because of other unit factors.
The NJR is a mandatory national audit of joint replacement activity. After gaining written
consent, operations are reported to the NJR by the healthcare provider at the time of surgery.
The dataset consisted of 981,269 linked primary THRs performed in England and Wales
between 1 April 2003 and 31 December 2017 with consent for data linkage. Data were cen-
sored either by death or administratively on 31 December 2017. After exclusion of THRs with
incomplete or inconsistent data or using metal-on-metal bearings, we were left with 664,761
primary THRs, in which osteoarthritis was the only indication for THR. Reasons for exclusion
at each stage are shown in Fig 1.
Statistical analysis
Statistical analysis was performed with Stata 15 (Stata Statistical Software: Release 15. College
Station, TX: StataCorp LLC, https://www.stata.com/). The exposure of interest was the unit in
which the THR was performed, and the 2 groups were THRs performed at the RD&E and
THRs performed in any other unit. The choice of the RD&E as the exposure group (rather
than any of the other units with “better than expected” survival results) is due to a lack of
Fig 1. Reasons for exclusion from analyses. A sequence is the order of operations recorded in the NJR for any patient.
All complete records will start with a primary operation. If a sequence starts with a revision, the primary was
performed before the NJR, outside the geographical coverage of the NJR, or data were not submitted to the NJR. THR,
total hip replacement; NJR, National Joint Registry for England, Wales, Northern Ireland and the Isle of Man.
https://doi.org/10.1371/journal.pmed.1003291.g001
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selection bias, in that every patient in this unit receives the same femoral stem, regardless of
age, sex, or indication. This lack of selection bias is unique to this unit.
The outcome of interest was revision of any part of the THR for any reason. All-cause revi-
sion was defined using the NJR definition as the addition, removal or modification of any part
of the construct [2]. The study population was all THRs implanted in the NJR; subgroup analy-
sis was performed for THRs using any type of cemented stem (hybrid or all-cemented con-
structs) as well as THRs using the Exeter V40 femoral stem (hybrid or all-cemented
constructs), the stem used by the RD&E.
Unadjusted survival estimates were calculated using the Kaplan–Meier (KM) method for all
included THRs, stratified by the exposure of interest [14]. Flexible parametric survival analysis
(FPSA), as described by Royston and Parmar, was used to look for time varying effects in the 2
exposure groups by plotting time-dependent against proportional hazards models [15]. FPSA
models were then used to compare THRs performed at the RD&E to those performed in any
other unit, having adjusted for age, sex, and American Society of Anesthesiology (ASA) score
at time of surgery and allowing for time varying effects. FPSA models were assessed visually
for goodness of fit against KM curves, in THRs using the Exeter V40 femoral stem. FPSA
modeling offers an advantage over more traditional semiparametric techniques, such as Cox
regression, because in addition to allowing effects to vary with time via cubic splines, they
allow us to estimate a baseline hazard function. This baseline hazard allows the estimation of
absolute effects, such as survival, for both groups given certain values of covariates, rather than
simply an estimate of the relative effect between the 2 groups (hazard ratio) as is given in Cox
regression. Graphs comparing revision estimates between the 2 exposure groups were fitted to
models for a 68-year-old female patient, to reflect the median age and most common sex
receiving primary THRs in the NJR. Restricted mean survival times were calculated using the
standardized survival package “stpm2_standsurv” [16].
Data were censored either by death, or administratively on 31 December 2017. THRs with
incomplete or inconsistent data or using metal-on-metal bearings (previously shown to dem-
onstrate poorer survival [17]) were excluded, and cases were included only where osteoarthri-
tis was the sole indication for THR. Reasons for exclusion at each stage are shown in Fig 1.
Sensitivity analyses
Other potential confounders were considered with a priori knowledge and focusing on vari-
ables that were determined before the choice of implant was made, rather than those poten-
tially related to implant choice and thus potentially mediators (e.g., surgical approach and
anesthetic). Socioeconomic status (SES) and body mass index (BMI) may also be important
potential confounders. Socioeconomic status was assessed using deciles of the Index of Multi-
ple Deprivation (IMD) organized by Lower Layer Super Output Areas (LSOAs), and BMI was
treated as a categorical variable using World Health Organization categories (<18.5, 18.5–
24.9, 25–29.9, 30–34.9, 35–39.9, and>40 kg/m2). S1 Table shows the distribution of BMI
across the strata for the overall cohort as well as the 2 exposure groups.
Cumulative revision estimates were explored restricting analyses to only THRs using the
same implant combinations as the exemplar center. Construct survival of THRs using the 5
most implanted cemented stems were explored to determine whether the similar results could
be achieved with other commonly used implants within the same type of construct fixation.
Missing data. Cases missing data on potential confounders (age, sex, ASA score, BMI, or
socioeconomic status) were retained in analyses that were not using that specific model as a
covariate. A table detailing the distribution of missing data on these covariates can be seen in
S2 Table. Data regarding SES were only available for patients operated in England, and BMI
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was missing in 30.1% of cases. Complete case analysis models including these variables were
completed as sensitivity analyses as multiple imputation of these data may introduce bias if
they are not missing truly at random [18].
Patient and public involvement
Patients were involved in the design of this study through the Patient Experience in Research
(PEPR) group at the Musculoskeletal Research Unit, University of Bristol [19], and in the NJR
Research Sub-committee who provided authority for this study. The same groups will be
involved in the dissemination of results. The choice of outcome of interest (all-cause revision
rather than revision for specific indications) was guided by the PEPR group.
Planning of analyses
The analysis plan was made prior to the start of all analyses and agreed on among co-authors.
No data-driven changes to the analysis plan were made.
This study is reported as per the Strengthening the Reporting of Observational Studies in
Epidemiology (STROBE) guideline (S1 STROBE Checklist). Approval for this study was
granted by the NJR Research Sub-committee (reference RSC2017/15). Written consent was
granted by patients for inclusion of their data and its use in research within the NJR.
Results
After exclusions, we were left with 664,761 primary THRs for analysis. The maximum follow-
up in the exemplar center group was 13.9 years and was 14.2 years in all other units. The
demographics and distribution of the THRs in each group can be seen in Table 1. Of the 6,230
cases performed at the RD&E, there were 83 different recorded “lead” surgeons who per-
formed a range from one THR to 992 THRs included in the study dataset. A total of 68.1% of
Table 1. Demographics and distribution of included total hip replacements.
All total hip replacements Constructs using a cemented
stem
Constructs using the same























Total, n 6,230 658,531 6,228 379,691 6,227 228,814
Female, n (%) 3,621 (58.1) 402,406 (61.1) 3,619 (58.1) 245,891 (64.8) 3,619 (58.1) 146,219 (63.9)
Mean age, SD 70.2 (10.6) 69.9 (10.1) 70.2 (10.6) 72.5 (9.2) 70.2 (10.6) 72.1 (9.3)
Mean body mass index, kg/m2 (SD) 28.6 (5.2) 28.7 (5.2) 28.6 (5.2) 28.4 (5.1) 28.6 (5.2) 28.5 (5.1)
Posterior approach, n (%) 5,553 (89.1) 377,802 (57.4) 5,552 (89.1) 208,652 (55.0) 5,551 (89.1) 136,090 (59.5)
American Society of Anesthesiologists score, n (%) I 963 (15.5) 98,212 (14.9) 963 (15.5) 48,189 (12.7) 963 (15.5) 29,987 (13.1)
II 4,499 (72.2) 462,006 (70.2) 4,497 (72.2) 265,746 (70.0) 4,496 (72.2) 159,682 (69.8)
III 756 (12.1) 95,507 (14.5) 756 (12.1) 63,868 (16.8) 756 (12.1) 38,050 (16.6)
IV & V 12 (0.2) 2,806 (0.4) 12 (0.2) 1,888 (0.5) 12 (0.2) 1,095 (0.5)
National Health Service funded, n (%) 6,123 (98.3) 552,907 (84.0) 6,121 (98.3) 317,950 (83.7) 6,120 (98.3) 193,566 (84.6)
Consultant as operating surgeon, n (%) 3,004 (48.2) 546,315 (83.0) 3,002 (48.2) 302,394 (79.6) 3,001 (48.2) 184,886 (80.8)
Cemented acetabulum, n (%) 4,927 (79.1) 263,055 (39.9) 4,927 (79.1) 244,644 (64.4) 4,926 (79.1) 147,578 (64.5)
Table demonstrating the demographics and distribution of all total hip replacements included in this study broken down by exposure groups and sensitivity analysis
subgroups.
https://doi.org/10.1371/journal.pmed.1003291.t001
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THRs were performed by 1 of 6 surgeons. The “lead” surgeon may be a consultant (attending),
fellow, or higher specialist trainee (resident) operating under the supervision of a consultant.
Crude analyses
The crude 10-year cumulative revision estimate of all THRs implanted at the RD&E was 1.7%
(95% CI 1.3–2.3). In all other units, the 10-year cumulative revision estimate for all THRs was
2.9% (95% CI 2.8–3.0; log-rank test P< 0.001); for just THRs using cemented stems, it was
2.6% (95% CI 2.5–2.7; log-rank test P = 0.007), and for just THRs using the Exeter V40 femoral
stem, it was 2.3% (95% CI 2.2–2.4) (log-rank test P = 0.05). Net revision estimates calculated
using 1-Kaplan–Meier curves can be seen in Fig 2; the number of hips at risk at all time points
for all analyses can be seen in S3 Table.
Adjusted analyses
A FPSA model was fitted for all THRs using the Exeter V40 femoral stem and showed excellent
“goodness of fit” (S1 Fig). Comparison of time-dependent and proportional hazards models
suggested the time-dependent model showed better fit (S2 Fig). After adjustment for age, sex,
and ASA and allowing for time varying effects, the relative revision estimates of each subgroup
of THRs (THRs using a cemented stem or THRs using the Exeter V40 femoral stem) modeled
for a 68-year-old, female patient, are shown in Fig 3A, Fig 3B and Fig 3C.
The femoral stem was paired with 9 different acetabular components in the RD&E, and
99% of these THRs used 1 of only 3 cups. In other units, the Exeter V40 femoral stem was
paired with 111 different acetabular components. Fig 3D shows a comparison of the 2 groups
if analyses are restricted to stem/cup combinations used at the RD&E. This restricted analysis
compares 6,227 performed in the RD&E with 148,295 THRs performed elsewhere. After 13.9
years, there is a discrepancy in restricted mean survival time (RMST) of 0.02 years (95% CI
−0.02 to 0.07; P = 0.33). A P value of 0.33 suggests there is little or no evidence of any difference
in survival of THRs after 13.9 years between those implanted in the RD&E compared with
Fig 2. Unadjusted 1-Kaplan–Meier revision estimates of total hip replacements in each subgroup. Comparison of
the all-cause construct revision estimates of total hip replacements performed in the exemplar center compared with
those performed in all other hospitals in the National Joint Registry.
https://doi.org/10.1371/journal.pmed.1003291.g002
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elsewhere when the same implants were used. Fig 4 shows how the difference in RMST
between the 2 subgroups changes over time. RMST is reported in years and estimates the dif-
ference in life expectancy of the THR between the 2 exposure groups, i.e., the extra time a THR
lasts because it was implanted in the RD&E. The difference in RMST changes slightly over
time, most notably at 2 time points, 3 years and at 10 years. This may reflect particular modes
of failure such as loosening of cups at 10 years, potentially due to cementation technique. It
should be noted that for the majority of time reported, the confidence intervals cross the null
Fig 3. FPSA adjusted for age, sex, and American Society of Anesthesiology score. Results presented for a 68-year-
old female patient with an American Society of Anesthesiology score of 2. FPSA, flexible parametric survival analysis.
https://doi.org/10.1371/journal.pmed.1003291.g003
Fig 4. Difference in RMST between total hip replacements performed at the RD&E and in all other hospitals
combined when using the same implants as those used at the RD&E. A demonstration of how the difference in
RMST varies between the 2 exposure groups using the flexible parametric model adjusted for age, sex, and American
Society of Anesthesiologists score and allowing for time varying effects. RMST, restricted mean survival time; RD&E,
Royal Devon & Exeter.
https://doi.org/10.1371/journal.pmed.1003291.g004
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value of 0. Graphically, it appears that for a short period there may be a transient center effect;
however, analysis of the entire period shows no such center effect.
Sensitivity analyses
A complete case analysis including socioeconomic status in the model excludes 16 cases from
the RD&E (0.3%) and 8,569 cases performed elsewhere (5.8%). The results of this model are
very similar to that described previously (S3 Fig). Complete case analysis with BMI included in
the model, again, shows roughly similar results; however, given the much higher proportion of
missing data, the CIs are wider (S4 Fig).
Analysis of the all-cause construct survival of THRs using the 5 most commonly implanted
cemented stems across the NJR to date, shows that other stems may achieve comparable per-
formance to the Exeter V40 femoral stem, but this is not true of all stems with the same mode
of fixation (S5 Fig).
Discussion
After 13.9 years, both crude and adjusted cumulative revision estimates showed better implant
survival when THRs were performed at the RD&E compared with elsewhere in the country. In
analyses adjusted for age, sex, and ASA score, these differences attenuated after restricting to
only cemented implants and disappeared when only THRs using the same implant combina-
tions as the RD&E were analyzed. This suggests that implant choice is responsible for the “bet-
ter than expected” results at the RD&E and not unit (or surgeon) factors.
We are unaware of any studies to date investigating the reasons why 1 unit achieves better
THR survival than others. This study suggests that when attempting to improve implant survi-
vorship, units performing THR, particularly those with “lower than expected” implant sur-
vival, should focus attention on choice of implant rather than other factors. The use of
implants without evidence of good long-term survival should be limited to well-controlled and
monitored studies or experiments. Although this study has focused on 1 single femoral stem
(the Exeter V40 femoral stem), we believe that the observed high survival would be reproduc-
ible with other well performing implants. Previous work by Deere and colleagues has com-
pared the survival of implant combinations after 10 years and provides a reference to
demonstrate other implant combinations with low revision rates [5]. The NJR annual report
provides a list of units with “better-than-expected” survival results as well as survival estimates
for individual stem/cup combinations and can act as a reference document to units wishing to
review their implant selection. These findings are of relevance to surgeons, commissioners,
and most importantly, patients when deciding whether to, where, and when to have a THR.
Patients should be encouraged to ask surgeons about the long-term survival evidence for the
implant they plan to use.
The strength of this study stems from the high number of patients included and the use of a
linked, national database with high capture of revision procedures. The lack of selection bias in
choice of femoral stem at the RD&E (our reference unit) is another strength. The data in this
study are, however, observational, and conclusions regarding causality must be interpreted
with caution. Our outcome is revision surgery, and although important, it is not the only
marker of success of a THR. Patient reported outcomes such as pain and function have not
been assessed and patients may have been unsuitable or unwilling to undergo a revision opera-
tion and as such a failure may have been misclassified as a success. We made no attempt to
restrict by bearing surfaces in this study, which may be a contributing factor in the longevity of
a THR; this would, however, have created several subgroups, which we wished to avoid so we
could maintain sample size. We would expect the complexity of cases to be generally
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representative of the UK population given the NHS referral system and have additionally
made attempts to adjust for potential confounders; however, there may still be some residual
confounding for variables with incomplete data or not captured by the dataset. There are likely
to be sequential hip replacements performed on different sides within the same patient
included in this study. We treated each hip as an individual case. There is a risk of failure of
one THR leading to subsequent failure of the other side in cases of infection; however, given
that this is also the case from other joint replacements (e.g., knee) or from other conditions
leading to a higher propensity to infection, we felt this risk was negligible and therefore did not
exclude these from analyses. The use of complete case analysis over multiple imputation for
handling missing covariates was also a potential weakness and may result in a loss of power by
restricting the sample size. Given the distribution of missing data (S1 Table) and the large
numbers offered by the registry, we felt that a complete case analysis was suitable for this
study, and any reduction in power would be negligible. We cannot exclude the possibility that
better surgeons may choose prostheses with lower revision rates.
The fact that the results seen at the RD&E were achieved with 83 different lead surgeons
supports the theory that the implant is the driver of improved survival results rather than the
skill of the individual surgeon. If this observed association is indeed true, the use of implants
with evidence of good survival should be encouraged throughout the health service. Further
work may focus on the effect of a change in implant use of a single hospital/unit on survival
results in time-series analyses. Although implant selection appears to be associated with
improved survival in THR, it is yet to be seen whether the same phenomenon is true in other
branches of medicine heavily reliant on implantable devices. Further research in other areas is
warranted to investigate this effect.
Conclusion
In this study, we found evidence suggesting that implant selection is associated with the long-
term survival of THRs rather than factors specific to a high-performing unit. Surgeons, com-
missioners, and patients should use this information when considering THR.
Supporting information
S1 STROBE Checklist. Annotated STROBE checklist detailing how this study meets the
criteria laid out in the STROBE statement. STROBE, Strengthening the Reporting of Obser-
vational Studies in Epidemiology.
(DOC)
S1 Fig. Demonstration of goodness of fit of flexible parametric survival analysis model for
total hip replacements using the Exeter V40 femoral stem. Goodness of fit was assessed visu-
ally using the above figure as well as by assessment of log-likelihood of different models. A
model with 5 knots was chosen as further knots provided more complexity with little improve-
ment in log-likelihood.
(TIF)
S2 Fig. Demonstration of nonproportionality of hazard of revision. The above figure dem-
onstrates that when using a flexible parametric survival analysis model that allows the hazard
of failure to vary with time to compare TD and PH models. There is an apparent difference
between the hazard of failure at the exemplar center and in all other units (the solid lines). The
fact that these solid lines cross is highly indicative of the fact that the hazards are not propor-
tional through the entire follow-up of the study. PH, proportional hazard; TD, time
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dependent.
(TIF)
S3 Fig. FPSA complete case analysis adjusted for age, sex, American Society of Anesthesiol-
ogy score, and socioeconomic status. Results presented for a 68-year-old female patient with
an American Society of Anesthesiology score of 2 and in the 10th decile of IMD organized by
LSOA. FPSA, flexible parametric survival analysis; IMD, Index of Multiple Deprivation;
LSOA, Lower Layer Super Output Area.
(TIF)
S4 Fig. FPSA complete case analysis adjusted for age, sex, American Society of Anesthesiol-
ogy score, socioeconomic status, and body mass index. Results presented for a 68-year-old
female patient with an American Society of Anesthesiology score of 2 and in the 10th decile of
IMD organized by LSOA and body mass index in World Health Organization category 2.
FPSA, flexible parametric survival analysis; IMD, Index of Multiple Deprivation; LSOA, Lower
Layer Super Output Area.
(TIF)
S5 Fig. Comparison of the all-cause construct survival of the 5 most used cemented stems
of all time in combination with any cup. A comparison of the probability of all-cause revision
(1 –Kaplan–Meier) for all constructs using the 5 most frequently implanted cemented femoral
stems, demonstrating the differences in revision estimates between these stems. This suggests
that the results demonstrated in this study may be achievable with other femoral stems.
(TIF)
S1 Table. Distribution of BMI across categories. A comparison of the distribution of BMI
between the 2 exposure categories (Royal Devon & Exeter hospital and all other hospitals com-
bined). BMI, body mass index.
(DOCX)
S2 Table. Distribution of missing data. Table detailing the distribution of missing data
between the exposure categories (Royal Devon & Exeter hospital and all other hospitals com-
bined).
(DOCX)
S3 Table. At-risk table. Table demonstrating the number of total hip replacements at risk at
each time point following operation. For use in the interpretation of previous survival graphs.
(DOCX)
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